GE HealthCare in Talks for Sofie
GE HealthCare Technologies is reportedly in talks to buy radiopharmaceutical developer Sofie Biosciences for one billion dollars. The potential acquisition aims to bolster the company diagnostic division.
Xurve View
Insights:
Xurve View

GE HEALTHCARE TECHNOLOGY is in talks to acquire Sofie Biosciences for $1 billion, people familiar with the matter said Sunday afternoon. The potential transaction would expand the medical device maker's presence in the radiopharmaceutical sector. A formal announcement could arrive as soon as the following week.









